These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28262237)

  • 21. Duration of anticoagulation after venous thromboembolism in real world clinical practice.
    Ageno W; Samperiz A; Caballero R; Dentali F; Di Micco P; Prandoni P; Becattini C; Uresandi F; Verhamme P; Monreal M;
    Thromb Res; 2015 Apr; 135(4):666-72. PubMed ID: 25708926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).
    Tosetto A; Iorio A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Douketis J
    J Thromb Haemost; 2012 Jun; 10(6):1019-25. PubMed ID: 22489957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry.
    Sada PR; López-Núñez JJ; Samperiz A; Soto MJ; Pedrajas JM; Porras JA; Peris ML; Olivé A; Debourdeau P; Pace F; Monreal M;
    Angiology; 2020 Feb; 71(2):131-138. PubMed ID: 31578072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients.
    Betancourt MT; Rodger MA
    Acta Chir Belg; 2007; 107(6):636-40. PubMed ID: 18274176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism - still a challenging issue.
    Elmi G; Di Pasquale G; Pesavento R
    Vasa; 2017 Mar; 46(2):87-95. PubMed ID: 28102773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
    Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
    J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
    Blanco-Molina A; Enea I; Gadelha T; Tufano A; Bura-Riviere A; Di Micco P; Bounameaux H; González J; Villalta J; Monreal M;
    Medicine (Baltimore); 2014 Oct; 93(17):309-317. PubMed ID: 25398066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
    Kuperman A; López-Reyes R; Bosco LJ; Lorenzo A; José B; Farge Bancel D; Alfonso M; Lumbierres M; Stemer G; Monreal Bosch M; Braester A;
    J Thromb Thrombolysis; 2018 Apr; 45(3):360-368. PubMed ID: 29383557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism.
    Bauer KA
    JAMA; 2011 Apr; 305(13):1336-45. PubMed ID: 21386068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in cancer patients with acute venous thromboembolism.
    Martín-Martos F; Trujillo-Santos J; Barrón M; Vela J; Javier Marchena P; Braester A; Hij A; Hernández-Blasco L; Verhamme P; Manuel M;
    Thromb Res; 2015 Feb; 135 Suppl 1():S12-5. PubMed ID: 25903526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
    Marchena PJ; Tzoran I; Brenner B; Martín M; Malý R; Bura-Riviere A; Valle R; Hernández-Blasco L; López-Sáez JB; Monreal M;
    Thromb Haemost; 2020 Apr; 120(4):620-626. PubMed ID: 32289861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term treatment of venous thromboembolism].
    Meyer G; Couturaud F
    Rev Prat; 2015 Feb; 65(2):208-13. PubMed ID: 25939225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study.
    Eischer L; Eichinger S; Kyrle PA
    J Thromb Haemost; 2014 May; 12(5):635-40. PubMed ID: 24548536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry.
    Pérez-Jacoiste Asín MA; Blanco Molina Á; Gómez-Cuervo C; Díaz-Pedroche MDC; Pedrajas JM; López-Núñez JJ; Gil-Díaz A; Alda-Lozano A; Bosevski M; Monreal M;
    Thromb Res; 2024 Sep; 241():109087. PubMed ID: 39018931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
    Madridano O; del Toro J; Lorenzo A; Martín M; Gómez Cerezo J; Hernández L; Prandoni P; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2015 Apr; 3(2):135-41.e1. PubMed ID: 26993830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
    Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
    Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
    Cote LP; Greenberg S; Caprini JA; Stone J; Arcelus JI; López-Jiménez L; Rosa V; Schellong S; Monreal M;
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):772-8. PubMed ID: 24798686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis.
    Khan F; Rahman A; Tritschler T; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Pinede L; Parpia S; Geersing GJ; Takada T; Bradbury CA; Andreozzi GM; Palareti G; Prandoni P; Buller HR; Mallick R; Hutton B; Thavorn K; Le Gal G; Rodger MA; Fergusson DA
    Thromb Haemost; 2022 Jul; 122(7):1186-1197. PubMed ID: 34753191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.